Founded by Genzyme Alumni, Cambridge's X4 Pharma Scores $27M Post author:Sam Post published:November 15, 2017 Post category:BioPharma X4 Pharma announced it had closed a $27M Series B financing. Source: BioSpace You Might Also Like Kirin Cashes Out of Amgen Drug Joint Venture for $780M October 30, 2017 It's Official: Ovid CEO Just Filed for $86 Million IPO April 11, 2017 A Look at the Deaths That Plagued Juno and Kite Pharma's CAR-T Trials June 26, 2017
